New York Life Investment Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,416
| Closed | -$404K | – | 1214 |
|
|
2024
Q1 | $404K | Buy |
21,416
+2,336
| +12% | +$44.1K | ﹤0.01% | 808 |
|
|
2023
Q4 | $364K | Sell |
19,080
-440
| -2% | -$8.4K | ﹤0.01% | 1081 |
|
|
2023
Q3 | $350K | Sell |
19,520
-3,075
| -14% | -$55.2K | ﹤0.01% | 1010 |
|
|
2023
Q2 | $459K | Sell |
22,595
-3,578
| -14% | -$72.7K | ﹤0.01% | 788 |
|
|
2023
Q1 | $477K | Buy |
+26,173
| New | +$477K | 0.01% | 957 |
|